Literature DB >> 10197076

A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.

E H Kemp1, R A Ajjan, E S Husebye, P Peterson, R Uibo, H Imrie, S H Pearce, P F Watson, A P Weetman.   

Abstract

OBJECTIVE: Recent studies have demonstrated an association between a microsatellite polymorphism of the CTLA-4 gene, specifically a 106 base pair allele, and both Graves' disease and autoimmune hypothyroidism. The aim of the present study was to determine whether the same polymorphism of the CTLA-4 gene was associated with autoimmune Addison's disease. DESIGN AND PATIENTS: We analysed a microsatellite polymorphism (variant lengths of a dinucleotide (AT)n repeat) within exon 3 of the CTLA-4 gene in the following groups: 21 English patients with non-associated Addison's disease, 18 with autoimmune polyglandular syndrome type 2 (APS2) and 173 healthy control subjects; 26 Norwegian patients with non-associated Addison's disease, 9 with autoimmune polyglandular syndrome type 1 (APS1), 17 with APS2 and 100 controls; 3 Finnish patients with non-associated Addison's disease, 5 with APS2 and 71 controls; 10 Estonian patients with non-associated Addison's disease, 2 with APS2 and 45 controls. MEASUREMENTS: The CTLA-4 microsatellite gene polymorphisms were determined by polymerase chain reaction amplification of genomic DNA and resolution of the products on sequencing gels.
RESULTS: The frequency of the 106 base pair allele was significantly increased in the groups of English patients with either non-associated Addison's disease or APS2 (P = 0.02 and 0.04, respectively), when compared to healthy controls with no clinical evidence or family history of either Addison's disease or any other autoimmune disorder. For Norwegian patients with either non-associated Addison's disease, APS1 or APS2, there was no association (P = 0.69, 0.62 and 0.97, respectively). This was also the case for Finnish patients with either non-associated Addison's disease or APS2 (P = 0.23 and 0.28, respectively) and for Estonian patients with either non-associated Addison's disease or APS2 (P = 0.34 and 0.29, respectively).
CONCLUSIONS: These results indicate that differences exist in the frequency of the 106 base pair allele in different population groups and in only the English population was the 106 base pair allele associated with Addison's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10197076     DOI: 10.1046/j.1365-2265.1998.00579.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Atypical chronic lymphocytic leukemia with polyglandular autoimmune endocrinopathy type II: a complex profile.

Authors:  Preetesh Jain; Luis Baez-Vallecillo; Yang O Huh; Ohad Benjamini; Lynne Abruzzo; Susan O'Brien; Naveen Pemmaraju; Michael Keating; Robert F Gagel; Zeev Estrov
Journal:  Leuk Lymphoma       Date:  2014-01-24

Review 3.  Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?

Authors:  C Betterle; F Lazzarotto; F Presotto
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

4.  Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population.

Authors:  M Terauchi; T Yanagawa; N Ishikawa; K Ito; T Fukazawa; H Maruyama; T Saruta
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

5.  Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes.

Authors:  Sharad Purohit; Robert Podolsky; Christin Collins; Weipeng Zheng; Desmond Schatz; Andy Muir; Diane Hopkins; Yi-Hua Huang; Jin-Xiong She
Journal:  J Autoimmune Dis       Date:  2005-10-31

6.  CTLA-4 as a genetic determinant in autoimmune Addison's disease.

Authors:  A S B Wolff; A L Mitchell; H J Cordell; A Short; B Skinningsrud; W Ollier; K Badenhoop; G Meyer; A Falorni; O Kampe; D Undlien; S H S Pearce; E S Husebye
Journal:  Genes Immun       Date:  2015-07-23       Impact factor: 2.676

7.  Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.

Authors:  Anna L Mitchell; Anette Bøe Wolff; Katie MacArthur; Jolanta U Weaver; Bijay Vaidya; Martina M Erichsen; Rebecca Darlay; Eystein S Husebye; Heather J Cordell; Simon H S Pearce
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

8.  Common genetic variation in the autoimmune regulator (AIRE) locus is associated with autoimmune Addison's disease in Sweden.

Authors:  Daniel Eriksson; Matteo Bianchi; Nils Landegren; Frida Dalin; Jakob Skov; Lina Hultin-Rosenberg; Argyri Mathioudaki; Jessika Nordin; Åsa Hallgren; Göran Andersson; Karolina Tandre; Solbritt Rantapää Dahlqvist; Peter Söderkvist; Lars Rönnblom; Anna-Lena Hulting; Jeanette Wahlberg; Per Dahlqvist; Olov Ekwall; Jennifer R S Meadows; Kerstin Lindblad-Toh; Sophie Bensing; Gerli Rosengren Pielberg; Olle Kämpe
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 9.  Autoimmune Addison disease: pathophysiology and genetic complexity.

Authors:  Anna L Mitchell; Simon H S Pearce
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

10.  CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.

Authors:  Liang Sun; Yunxiao Meng; Yanchen Xie; Hua Zhang; Zheng Zhang; Xiaoxia Wang; Bin Jiang; Wei Li; Yao Li; Ze Yang
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.